We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

A&G Pharmaceutical and Celltrion Announce Bioprocess Development and Manufacturing Agreement

News   Jun 09, 2006

 
A&G Pharmaceutical and Celltrion Announce Bioprocess Development and Manufacturing Agreement
 
 
Advertisement
 

RELATED ARTICLES

Altering Roundworm Proteins To Develop Anti-Aging Drugs

News

Researchers have been able to alter creatures’ lifespans by altering the activity of proteins found in roundworm cells that tell them to convert sugar into energy when their cellular energy is running low. Humans also have these proteins, offering up intriguing possibilities for developing longevity-promoting drugs.

READ MORE

Expert Panel Makes Weak Recommendation for Use of Remdesivir To Treat Severe COVID-19

News

International experts have made a weak recommendation for the use of remdesivir in patients with severe COVID-19, advising continuation of patient enrolment for ongoing clinical trials of remdesivir to enable the collection of additional data.

READ MORE

Lab Profiles That Differentiate MIS-C From COVID-19 in Children Identified

News

Researchers from Children’s Hospital of Philadelphia report important data that differentiate MIS-C from severe COVID-19 in children and suggest that MIS-C is a post-infectious syndrome related to COVID-19 but distinct from KD.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE